MYLAN LABS
EBITDA. Total Debt Enterprise Value Price/Earning Price/Sales. Price/Book. Price /Cash. EV/EBITDA. Teva. TEVA. 67.03. -0.19. 128.10. 8586.54. 414.80. Mylan ...
http://www.yale.edu/ybps/YERC/ValuationPRX.pdf...
|
Mylan Inc. - Wikipedia, the free encyclopedia
In October 2007 Mylan bought the generics arm of Merck KGaA, and renamed the entire corporation from Mylan Laboratories Inc. to Mylan Inc. ...
http://en.wikipedia.org/wiki/Mylan_Inc....
|
MYL: Profile for Mylan Inc. - Yahoo! Finance
The company was formerly known as Mylan Laboratories Inc. and changed its name to Mylan Inc. in October 2007. Mylan Inc. was founded in 1961 and is based in ...
http://biz.yahoo.com/p/M/MYL.html...
|
Mylan Laboratories Completes Matrix Laboratories Transaction ...
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL ...
http://www.matrixlabsindia.com/inside/090107.asp...
|
Google Finance: Mylan Laboratories Inc.
Discussions for Mylan Laboratories Inc. View all discussions. Start a new discussion. My starred discussions · My profile. ELTP - WOW - MUST READ DD - BIG ...
http://www.google.com/group/google.finance.24946/t/6c06f79ae...
|
BioSpace - Mylan Laboratories Inc. News, Search Jobs, Events
Mylan Laboratories Inc. 1500 Corporate Drive Suite 400 ... Mylan Laboratories Inc. (MYL) Reports Adjusted Diluted EPS of $0.09 for the Quarter Ended March ...
http://www.biospace.com/company_profile.aspx?CompanyId=2414...
|
News: Mylan Labs to Acquire Controlling Interest in Matrix Labs ...
Pittsburgh-based Mylan Labs will purchase 71.5% of the shares of Hyderabad, India-based Matrix Labs for about $736 million. Matrix will remain a publicly ...
http://www.genengnews.com/news/bnitem.aspx?name=4853204...
|
Mylan Laboratories Inc. Completes Matrix Laboratories Limited ...
9 Jan 2007 ... Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., ...
http://www.biospace.com/news_story.aspx?NewsEntityId=42047...
|
Do Third-Generation Beta-blockers Have a Role in Hypertension ...
Mylan Laboratories press release, June 1, 2005: Mylan Laboratories receives Approvable Letter for its next generation beta-blocker nebivolol. ...
http://www.medscape.com/viewarticle/558880_5...
|
Mylan Laboratories Inc. Announces Tentative FDA Approval for ...
12 Dec 2007 ... Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ...
http://www.biospace.com/news_story.aspx?NewsEntityId=80271...
|